Generics

News

Could a Novo error set up early GLP-1 generics in Canada?

Reports say Novo Nordisk may have inadvertently let generics of its GLP-1 drug semaglutide for diabetes and obesity launch in Canada early next year.

News

Jazz pays $145m to resolve Xyrem antitrust disputes

Jazz Pharma has offered to pay $145m to settle claims it paid to prevent generic versions of its narcolepsy drug Xyrem from reaching the US market.

News

President Trump signing an Order at his desk in the Oval Office

Pharma tariffs "will hurt US consumers most of all"

If pharmaceuticals are included in President Trump's 'Liberation Day' tariffs, it is US consumers who will suffer the most, says a new report.

News

an older man's hand with a pill in his palm

FDA approves first generics of anticoagulant Xarelto

The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto.

News

Hand pointing to viewer through map of China

Trump tariffs 'would strain the pharma supply chain'

Pharma organisations in the US have said that Trump's tariffs plan could drive up the cost of generics, block supply chains and worsen drug shortages.

R&D

Life Sciences Industry Report - Part 7 cover image

Life Sciences Industry Report - Biologics and Generics

The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.

Could a Novo error set up early GLP-1 generics in Canada?

Jazz pays $145m to resolve Xyrem antitrust disputes

Pharma tariffs "will hurt US consumers most of all"

FDA approves first generics of anticoagulant Xarelto

Trump tariffs 'would strain the pharma supply chain'

Life Sciences Industry Report - Biologics and Generics

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

Generics

Editor's Picks